Tag:
Jubilant Biosys
Latest Headlines
Latest Headlines
Lilly bows out of early-stage R&D joint venture with India's Jubilant
Eli Lilly ( $LLY ) is exiting a joint venture it started with India's Jubilant that set out to provide a low-cost outsourcing model for early-stage drug development work. An official for Jubilant Life
Jubilant signs MOU with Alabama researchers
India's Jubilant Organosys, the University of Alabama at Birmingham (UAB), and Southern Research Institute will form a joint venture that will focus on developing affordable treatments for the
Endo Pharma, Jubilant in oncology pact
U.S. based Endo Pharmaceuticals and Jubilant Biosys--a Jubilant Organosys unit--have signed a three-year pact to discover and develop oncology drugs. Under the partnership, Bangalore-based Jubilant
India's Jubilant inks $220M R&D deal with AZ
India's Jubilant Biosys has struck a new research and development deal with AstraZeneca that could be worth up to $220 million. The drug developer, which is already partnered in a separate
